Osaic Holdings
CADL icon

Osaic Holdings’s Candel Therapeutics CADL Stock Holding History

Osaic Holdings’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.6K Sell
6,372
-2
-0% -$15 ﹤0.01% 5272
2026
Q1 		$31.2K Sell
6,374
-105
-2% -$571 ﹤0.01% 5552
2025
Q4 		$36.6K Sell
6,479
-8,384
-56% -$45.1K ﹤0.01% 5457
2025
Q3 		$86K Buy
14,863
+2,988
+25% +$17.3K ﹤0.01% 4914
2025
Q2 		$60.1K Sell
11,875
-1,930
-14% -$9.93K ﹤0.01% 4915
2025
Q1 		$78K Buy
13,805
+10,778
+356% +$88.1K ﹤0.01% 4363
2024
Q4 		$26.3K Buy
+3,027
New +$17.9K ﹤0.01% 5154
2024
Q3 		– Sell
-25,800
Closed -$160K – 7414
2024
Q2 		$160K Buy
+25,800
New +$194K ﹤0.01% 3747

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's CADL Position: Q2 2026 in Review

Osaic Holdings reduced its Candel Therapeutics (CADL) stake by 0.03% in Q2 2026, selling an estimated $15 and leaving 6,372 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5272.

Osaic Holdings first reported a position in CADL in Q2 2024 and has held it in 8 quarters since. The position peaked at $160K in Q2 2024. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Osaic Holdings held 6,372 shares of Candel Therapeutics worth $65.6K as of Q2 2026.
  • Osaic Holdings sold 2 Candel Therapeutics shares in Q2 2026, an estimated $15.
  • Candel Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5272 holding.
  • Osaic Holdings first reported a position in Candel Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Candel Therapeutics position peaked at $160K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.